Decreased Serum CTRP3 level was associated with connective tissue diseases

• Published in: Heliyon 2024-08, Vol.10 (16), p.e36322, Article e36322
• Main Authors: Ma, Lisha, Lin, Jiangbo, Shao, Miaoli, Chen, Binxuan, Zhou, Renfang, Shi, Jianfeng
• Format: Article
• Language: English
• Subjects: Connective tissue diseases; CTRP3; CTRP9; SLE
• ISSN: 2405-8440; 2405-8440
• DOI: 10.1016/j.heliyon.2024.e36322

Complement C1q tumor necrosis factor-related protein 3 (CTRP3) and 9 (CTRP9) are two of the most extensively studied adipokines, known for their diverse biological functions. However, it remains unclear whether serum levels of CTRP3 or CTRP9 are associated with connective tissue diseases (CTD). Serum CTRP3 and CTRP9 levels were measured by enzyme-linked immune sorbent assay (ELISA) and analyzed in patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), primary Sjogren's syndrome (pSS), ankylosing spondylitis (AS), undifferentiated connective tissue disease (UCTD), as well as in healthy controls (HCs). Serum CTRP3 levels were all significantly lower in patients with RA, SLE, pSS and AS compared with HCs. However, there were no significant differences in serum CTRP9 levels between patients with RA, SLE, pSS, or AS and HCs. In pSS patients, CTRP3 showed a weak correlation with blood glucose, creatinine, and urine acid in pSS patients, while no correlations were observed between serum CTRP3 levels and clinical or laboratory indices in RA, SLE or AS patients. Stable associations between CTRP3 and RA, SLE, pSS and AS were evaluated using multivariate logistics regression analysis. Receiver operating characteristic (ROC) curves were plotted to evaluated CTRP3 as a marker for RA, SLE, pSS and AS, yielding area under curve (AUC) values of 0.691, 0.727, 0.658 and 0.694, respectively. Decreased serum CTRP3 levels were associated with RA, SLE, pSS and AS. •Serum CTRP3 levels decreased in patients with RA, SLE, pSS or AS.•Serum CTRP3 level was an independent predictor for RA, SLE, pSS and AS.•Serum CTRP3 was a potential biomarker for distinguishing patients with RA, SLE, pSS or AS from healthy controls.